«

»

Stanford researchers to test Paxlovid as a long COVID-19 treatment

Researchers from Stanford (Calif.) University are enrolling 200 participants in a phase 2 study to see if Paxlovid could be used to treat the millions of Americans experiencing long COVID-19, according to a Nov. 21 entry on clinicaltrials.gov. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive